UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase–substrate interactions in eukaryotic species

Xun Wang(Beijing Proteome Research Center), Yang Li(Beijing Proteome Research Center), Mengqi He(Beijing Proteome Research Center), Xiangren Kong(Hebei University), Peng Jiang(Anhui Medical University), Xi Liu(Hebei University), Lihong Diao(Beijing Proteome Research Center), Xinlei Zhang, Honglei Li, Xinping Ling(Hebei University), Simin Xia(Anhui Medical University), Zhongyang Liu(Beijing Proteome Research Center), Yuan Liu(Beijing Proteome Research Center), Chun‐Ping Cui(Beijing Proteome Research Center), Yan Wang(Beijing Proteome Research Center), Liujun Tang(Beijing Proteome Research Center), Lingqiang Zhang(Anhui Medical University), Fuchu He(Beijing Proteome Research Center), Dong Li(Anhui Medical University)
Nucleic Acids Research
October 6, 2021
Cited by 245Open Access
Full Text

Abstract

As an important post-translational modification, ubiquitination mediates ∼80% of protein degradation in eukaryotes. The degree of protein ubiquitination is tightly determined by the delicate balance between specific ubiquitin ligase (E3)-mediated ubiquitination and deubiquitinase-mediated deubiquitination. In 2017, we developed UbiBrowser 1.0, which is an integrated database for predicted human proteome-wide E3-substrate interactions. Here, to meet the urgent requirement of proteome-wide E3/deubiquitinase-substrate interactions (ESIs/DSIs) in multiple organisms, we updated UbiBrowser to version 2.0 (http://ubibrowser.ncpsb.org.cn). Using an improved protocol, we collected 4068/967 known ESIs/DSIs by manual curation, and we predicted about 2.2 million highly confident ESIs/DSIs in 39 organisms, with >210-fold increase in total data volume. In addition, we made several new features in the updated version: (i) it allows exploring proteins' upstream E3 ligases and deubiquitinases simultaneously; (ii) it has significantly increased species coverage; (iii) it presents a uniform confidence scoring system to rank predicted ESIs/DSIs. To facilitate the usage of UbiBrowser 2.0, we also redesigned the web interface for exploring these known and predicted ESIs/DSIs, and added functions of 'Browse', 'Download' and 'Application Programming Interface'. We believe that UbiBrowser 2.0, as a discovery tool, will contribute to the study of protein ubiquitination and the development of drug targets for complex diseases.


Related Papers

No related papers found

Powered by citation graph analysis